MyFinsight
Home
Blog
About
Back
Cash Flow
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)
source: myfinsight.com
Borrowings from notes
payable to related...
$82,873
(-63.11%↓ Y/Y)
Net cash provided by
(used in) financing...
$24,037
(-89.30%↓ Y/Y)
Canceled cashflow
$58,836
Net increase
(decrease) in cash
-$32
(-103.06%↓ Y/Y)
Canceled cashflow
$24,037
Changes in derivative
liability
$623,200
(65.61%↑ Y/Y)
Common stock issued for
expenses
$47,897
(-53.82%↓ Y/Y)
Increase (decrease) in
interest expense...
$8,754
(-51.13%↓ Y/Y)
Increase (decrease) in
accounts payable
$468
(-42.08%↓ Y/Y)
Repayment of notes payable
to related parties
$58,836
Net cash provided by
(used in) operating...
-$24,069
(89.24%↑ Y/Y)
Canceled cashflow
$680,319
Net income (loss)
-$637,785
(9.15%↑ Y/Y)
Increase ( decrease) in
unearned income
-$31,640
(66.67%↑ Y/Y)
(increase) decrease in
accounts receivable
$27,425
(-66.67%↓ Y/Y)
Increase (decrease) in
accrued expenses
-$7,538
(-106.89%↓ Y/Y)
Back